0001365618-12-000002.txt : 20120705
0001365618-12-000002.hdr.sgml : 20120704
20120705183916
ACCESSION NUMBER: 0001365618-12-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120702
FILED AS OF DATE: 20120705
DATE AS OF CHANGE: 20120705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hove Anders D
CENTRAL INDEX KEY: 0001365618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 12949173
MAIL ADDRESS:
STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2012-07-02
0001411158
Anacor Pharmaceuticals Inc
ANAC
0001365618
Hove Anders D
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
1
0
1
0
Common Stock
2012-07-02
4
J
0
900000
0
D
3725535
I
By Funds and LLC's
Common Stock
2012-07-02
4
J
0
79450
0
A
3804985
I
By Funds and LLC's
On July 2, 2012, Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP"), Venrock Entrepreneurs Fund IV, L.P. ("VEF4"), Venrock Healthcare Capital Partners, L.P. ("VHCP") and VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest") (collectively, the "Venrock Funds") distributed an aggregate of 900,000 shares of the common stock of the Issuer to their respective partners pro rata based on their respective interests in the Venrock Funds (the "Distribution").
Following the Distribution, the Venrock Funds' shares are held as follows: 1,721,350 shares held by VA4, 351,036 shares held by VP, 42,293 shares held by VEF4, 1,361,755 shares held by VHCP and 249,101 shares held by VHCP Co-Invest. Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4 and VHCP Management except to the extent of his indirect pecuniary interest therein.
In the Distribution, VM4 received 5,663 shares, VPM received 1,193 shares, VEFM4 received 82 shares, VHCP Management received 12,335 shares, Venrock Associates V, L.P. ("VA5") received 55,474 shares and Venrock Partners V, L.P. ("VP5") received 4,703 shares. Venrock Management V, LLC ("VM5") and Venrock Partners Management V, LLC ("VPM5") are the sole general partners of VA5 and VP5, respectively, and may be deemed to beneficially own these shares. Dr. Hove is a member of VM5 and VPM5. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA5, VP5, VM5 and VPM5 except to the extent of his indirect pecuniary interest therein. For VM4, VPM, VEFM4 and VHCP Management, this represents a change in form of ownership from indirect to direct but does not represent a change in beneficial ownership.
/s/ Anders D. Hove
2012-07-05